Genetic Mechanisms in Aspirin-Exacerbated Respiratory Disease
2012

Genetic Mechanisms in Aspirin-Exacerbated Respiratory Disease

publication Evidence: moderate

Author Information

Author(s): Nami Shrestha Palikhe, Kim Seung-Hyun, Jin Hyun Jung, Hwang Eui-Kyung, Nam Young Hee, Park Hae-Sim

Primary Institution: Ajou University School of Medicine

Hypothesis

The study investigates the genetic mechanisms associated with aspirin-exacerbated respiratory disease (AERD).

Conclusion

The study highlights the role of various genetic markers in the susceptibility to AERD and emphasizes the need for further research to identify biomarkers for early diagnosis.

Supporting Evidence

  • Aspirin-exacerbated respiratory disease (AERD) is linked to genetic factors affecting leukotriene production.
  • Specific SNPs in genes like LTC4S and ALOX5 have been associated with increased susceptibility to AERD.
  • Overexpression of CysLTR1 in AERD patients suggests a genetic basis for aspirin intolerance.
  • Genome-wide studies have identified several genetic variants that may contribute to AERD.

Takeaway

Some people have a bad reaction to aspirin because of their genes, and scientists are trying to find out which genes are involved so they can help diagnose and treat this problem better.

Methodology

The study reviews genetic studies related to AERD and discusses various genetic markers and their associations with the disease.

Limitations

The findings may not be applicable across all ethnic groups, and replication studies are needed.

Digital Object Identifier (DOI)

10.1155/2012/794890

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication